FDA approves Moderna's mRNA seasonal flu vaccine
Thursday, August 6, 2026 9:33AM
The vaccine, mFLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
WPVI
Copyright © 2026 WPVI-TV. All Rights Reserved.